Sandi See Tai – Biography
Last update: April 13, 2026Executive profile
Sandi was Chief Development Officer for Lexeo Therapeutics. Sandi See Tai joined CSL in 2026.
Sandi See Tai is currentlyVice President of Research and Development, Cardiovascular & Renal at CSL - View - CSL org chart
Create your alert
to follow the career of Sandi See Tai.
More about Sandi See Tai
Do you need to know more about Sandi See Tai? More results.
Participate
Social media
- Sandi See Tai on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Sandi See Tai
The colleagues of Sandi See Tai
Company Colleagues
- At CSL, Sandi See Tai has 109 colleagues including Gordon Naylor (Interim CEO & Director), Brian McNamee (Chairman of the Board)…
Industry Colleagues
- In the Pharmaceuticals industry, Sandi See Tai has 22,991 colleagues in 1,914 companies located in 68 countries. 10,821 executive movements have been recorded in the last 12 months. Learn more about Pharmaceuticals.
Report an error
Update the org chart details of Sandi See Tai.
Get in Touch
Here are a few tips for establishing great contacts.
